BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26958241)

  • 1. Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm.
    Peters LB; Bodenreider O
    AMIA Annu Symp Proc; 2015; 2015():1034-41. PubMed ID: 26958241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting Potential Medication Selection Errors During Outpatient Pharmacy Processing of Electronic Prescriptions With the RxNorm Application Programming Interface: Retrospective Observational Cohort Study.
    Lester CA; Tu L; Ding Y; Flynn AJ
    JMIR Med Inform; 2020 Mar; 8(3):e16073. PubMed ID: 32044760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the drug ontology with semantically-rich representations of National Drug Codes and RxNorm unique concept identifiers.
    Bona JP; Brochhausen M; Hogan WR
    BMC Bioinformatics; 2019 Dec; 20(Suppl 21):708. PubMed ID: 31865907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminology Status APIs - Mapping Obsolete Codes to Current RxNorm, SNOMED CT, and LOINC Concepts.
    Peters L; Nguyen T; Bodenreider O
    Stud Health Technol Inform; 2017; 245():1333. PubMed ID: 29295414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the RxNorm web services API for quality assurance purposes.
    Peters L; Bodenreider O
    AMIA Annu Symp Proc; 2008 Nov; 2008():591-5. PubMed ID: 18999038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication Reconciliation during Transitions of Care Across Institutions: A Quantitative Analysis of Challenges and Opportunities.
    Araya A; Thornton LR; Kwon D; Ferguson GM; Highfield LD; Hwang KO; Holmes HM; Bernstam EV
    Appl Clin Inform; 2023 Oct; 14(5):923-931. PubMed ID: 37726022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitness for Use of Anatomical Therapeutic Classification for Real World Data Research.
    Reinecke I; Henke E; Peng Y; Sedlmayr M; Bathelt F
    Stud Health Technol Inform; 2023 May; 302():711-715. PubMed ID: 37203475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions.
    Lester CA; Flynn AJ; Marshall VD; Rochowiak S; Rowell B; Bagian JP
    J Am Med Inform Assoc; 2022 Aug; 29(9):1471-1479. PubMed ID: 35773948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Medical Vocabulary Updates in a Clinical Data Warehouse: An RxNorm Case Study.
    Podchiyska T; Hernandez P; Ferris T; Weber S; Lowe HJ
    AMIA Annu Symp Proc; 2010 Nov; 2010():477-81. PubMed ID: 21347024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Partners Master Drug Dictionary to RxNorm using an NLP-based approach.
    Zhou L; Plasek JM; Mahoney LM; Chang FY; DiMaggio D; Rocha RA
    J Biomed Inform; 2012 Aug; 45(4):626-33. PubMed ID: 22142948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the implementation of RxNorm in ambulatory electronic prescriptions.
    Dhavle AA; Ward-Charlerie S; Rupp MT; Kilbourne J; Amin VP; Ruiz J
    J Am Med Inform Assoc; 2016 Apr; 23(e1):e99-e107. PubMed ID: 26510879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCRx: Canadian Drug Ontology.
    Nikiema JN; Liang MQ; Després P; Motulsky A
    Stud Health Technol Inform; 2021 May; 281():367-371. PubMed ID: 34042767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling complex queries to drug information sources through functional composition.
    Peters L; Mortensen J; Nguyen T; Bodenreider O
    Stud Health Technol Inform; 2013; 192():692-6. PubMed ID: 23920645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing and evaluating terminology services application programming interfaces: RxNav, UMLSKS and LexBIG.
    Pathak J; Peters L; Chute CG; Bodenreider O
    J Am Med Inform Assoc; 2010; 17(6):714-9. PubMed ID: 20962136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a unified understanding of drug-drug interactions: mapping Japanese drug codes to RxNorm concepts.
    Kawakami Y; Matsuda T; Hidaka N; Tanaka M; Kimura E
    J Am Med Inform Assoc; 2024 Jun; 31(7):1561-1568. PubMed ID: 38758661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling Hierarchical View of RxNorm with NDF-RT Drug Classes.
    Palchuk MB; Klumpenaar M; Jatkar T; Zottola RJ; Adams WG; Abend AH
    AMIA Annu Symp Proc; 2010 Nov; 2010():577-81. PubMed ID: 21347044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalized names for clinical drugs: RxNorm at 6 years.
    Nelson SJ; Zeng K; Kilbourne J; Powell T; Moore R
    J Am Med Inform Assoc; 2011; 18(4):441-8. PubMed ID: 21515544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of RxNorm for Representing Ambulatory Prescriptions.
    O'Neill SM; Bell DS
    AMIA Annu Symp Proc; 2010 Nov; 2010():562-6. PubMed ID: 21347041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating historical clinical and financial data for pharmacological research.
    Deshmukh VG; Sower NB; Hunter CY; Mitchell JA
    BMC Med Res Methodol; 2011 Nov; 11():151. PubMed ID: 22099213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.
    Pathak J; Chute CG
    J Am Med Inform Assoc; 2010; 17(4):432-9. PubMed ID: 20595311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.